Latest filing published 08 Dec 2021 for HLS Therapeutics Inc., €53k.
All filings by Gilbert Godin on record concern HLS Therapeutics Inc. We count 8 filings; the first trade dates from 12 March 2018 and the latest from 8 December 2021.
Every open-market trade on record is a purchase: 7 purchases worth €156k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2021, the count stands at 2 purchases and no sales.
Half of the purchases are above €22k and half below. No cluster: in 7 purchases, no other insider of the company bought within 30 days.
Most recently, on 8 December 2021, the filings show an open-market purchase worth €53k in HLS Therapeutics Inc. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations